Integra LifeSciences is set to drop its earnings report with neutral expectations—revenue is forecast to hold steady after a recent beat, but past misses loom. While competitors like Intuitive Surgical and Abbott surged, Integra’s stock has outperformed the sector, trading near $19.60 with a target around $18.63. Analysts see little change in outlook, making this a quiet, hold-the-line moment for the healthcare equipment player.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
